Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
26 March 2025
| Name: | VOLPARA HEALTH TECHNOLOGIES LIMITED (VHT) |
| ISIN: | NZVHTE0001S6 |
| Date of Listing: | 27 April 2016 |
| Date of Delisting: | 22 May 2024 |
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 22 May 2024.Legal Status:
ACN: 609 946 867
Registration Date: 20 January 2016
Capital Gains Tax (CGT) Status:
To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
REGISTRY:
Boardroom Pty Ltd
Level 8, 210 George Street, Sydney NSW 2000
Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail
delisted at entity's request under Listing Rule 17.11 | 22/05/2024 |
we understand Lunit Inc. was successful with an offer of AU$1.15 cash per Volpara share | 22/05/2024 |
Volpara achieved record revenue from customer contracts, surpassing the guidance and reaching NZ$42.7M, up 22% (20% constant currency). Initial guidance ranged between NZ$40.0M and NZ$42.0M. Normalised non-GAAP EBITDA1 improved 91% to -NZ$0.5M "“ the Company achieved its first ever positive Normalised non-GAAP EBITDA half-year of NZ$0.8M. Volpara achieved both operating and net free cash flow2 positive in FY24, improving by NZ$6.6m (or 171%) to NZ$2.7m and NZ$7.1M (or 101%) to NZ$0.1M respectively "“ both significantly ahead of guidance. Cash receipts from operations improved 20% (18% constant currency) to NZ$46.5m. | 21/05/2024 |
The company announces that the scheme of arrangement with Lunit Inc. has been implemented. Following implementation, Lunit holds all of the shares in Volpara. | 21/05/2024 |
The company releases a notification of cessation of securities. | 13/05/2024 |
The company announced that it had been granted final orders from the New Zealand High Court in relation to the scheme of arrangement with Lunit Inc. | 06/05/2024 |
The securities of Volpara Health Technologies Limited will be suspended from quotation at the close of trading on Friday, 3 May 2024 under Listing Rule 17.2, following receipt of final orders from the High Court of New Zealand approving the scheme of arrangement by which Lunit Inc. will acquire all of the issued shares in VHT. | 03/05/2024 |
listed entity carried for record purposes only | 27/04/2016 |
delisted at entity's request under Listing Rule 17.11 | 22/05/2024 |
we understand Lunit Inc. was successful with an offer of AU$1.15 cash per Volpara share | 22/05/2024 |
Volpara achieved record revenue from customer contracts, surpassing the guidance and reaching NZ$42.7M, up 22% (20% constant currency). Initial guidance ranged between NZ$40.0M and NZ$42.0M. Normalised non-GAAP EBITDA1 improved 91% to -NZ$0.5M "“ the Company achieved its first ever positive Normalised non-GAAP EBITDA half-year of NZ$0.8M. Volpara achieved both operating and net free cash flow2 positive in FY24, improving by NZ$6.6m (or 171%) to NZ$2.7m and NZ$7.1M (or 101%) to NZ$0.1M respectively "“ both significantly ahead of guidance. Cash receipts from operations improved 20% (18% constant currency) to NZ$46.5m. | 21/05/2024 |
The company announces that the scheme of arrangement with Lunit Inc. has been implemented. Following implementation, Lunit holds all of the shares in Volpara. | 21/05/2024 |
The company releases a notification of cessation of securities. | 13/05/2024 |
The company announced that it had been granted final orders from the New Zealand High Court in relation to the scheme of arrangement with Lunit Inc. | 06/05/2024 |
The securities of Volpara Health Technologies Limited will be suspended from quotation at the close of trading on Friday, 3 May 2024 under Listing Rule 17.2, following receipt of final orders from the High Court of New Zealand approving the scheme of arrangement by which Lunit Inc. will acquire all of the issued shares in VHT. | 03/05/2024 |
listed entity carried for record purposes only | 27/04/2016 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 02/06/2023 | Teri Thomas | 3,577 | $0.712 | $2,546 | |
| 29/06/2022 | John Pavlidis | 69,100 | $0.410 | $28,331 | |
| 22/06/2022 | John Pavlidis | 30,000 | $0.450 | $13,500 | |
| 16/06/2022 | John Diddams | 30,001 | $0.560 | $16,801 | |
| 15/06/2022 | Paul Reid | 115,000 | $0.582 | $66,959 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Teri Thomas | Managing Director, CEO | 21/04/2022 |
| Craig Hadfield | CFO, Company Secretary | 02/03/2017 |
| Brandon Suh | Director | 21/05/2024 |
| Anthony Paek | Director | 21/05/2024 |
| Fred Struve | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Paul Reid | Chairman, Independent Director | 22/03/2018 | 21/05/2024 |
| Ann Custin | Independent Director | 01/09/2021 | 21/05/2024 |
| Karin Lindgren | Independent Director | 31/01/2020 | 21/05/2024 |
| Mark Bouw | Non Exec Director | 01/01/2023 | 21/05/2024 |
| John Pavlidis | Non Exec Director | 27/04/2016 | 21/05/2024 |
| Roger Allen | Director | 27/04/2016 | 21/05/2024 |
| John Diddams | Non Exec Director | 27/04/2016 | 20/08/2022 |
| Ralph Highnam | Executive Director, CEO | 27/04/2016 | 21/04/2022 |
| Monica Saini | Non Exec Director | 24/01/2018 | 18/08/2021 |
| Mike Brady | Non Exec Director | 27/04/2016 | 31/01/2020 |
| Lyn Swinburne | Non Exec Director | 27/04/2016 | 25/08/2018 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
